Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sandoz Gets US Denosumab Approvals – But When Will They Launch?
FDA Also Grants Interchangeability Designation For First Biosimilars To Prolia And Xgeva
Mar 06 2024
•
By
David Wallace
Sandoz has received two denosumab biosimilar approvals • Source: Shutterstock
More from Biosimilars
More from Products